Inflammatory Bowel Disease in Cats: Long-Term Welfare Management

Feline IBD causes chronic gastrointestinal symptoms requiring accurate diagnosis and individualized management to maintain quality of life.

Key Facts

Feline IBD encompasses lymphocytic-plasmacytic enteritis, eosinophilic gastroenteritis, and other forms
Distinguishing IBD from small cell lymphoma requires intestinal biopsy - needle aspirates are insufficient
Signs include chronic vomiting, diarrhea, weight loss, and reduced appetite
Prednisolone is the mainstay of treatment for most IBD forms
Chlorambucil is added for small cell lymphoma or prednisolone-refractory IBD
Dietary trials with novel protein or hydrolyzed protein diets sometimes achieve remission without medication
Cobalamin (B12) deficiency is common in cats with chronic gut disease and requires supplementation

Welfare Considerations

Chronic vomiting, diarrhea, and weight loss cause ongoing discomfort and reduce quality of life in cats with IBD. The challenge of distinguishing IBD from small cell lymphoma matters for welfare because treatment protocols differ - underdiagnosis leads to suboptimal treatment. Accurate diagnosis via biopsy followed by appropriate therapy achieves remission in most cats. Regular monitoring of weight, appetite, and symptom frequency enables medication adjustment to maintain the lowest effective dose with the best quality of life.

What You Can Do

Pursue intestinal biopsy for accurate diagnosis - distinguish IBD from small cell lymphoma
Implement dietary trials with novel protein diets before or alongside medication in mild cases
Monitor weight, vomiting frequency, and appetite as welfare outcome measures
Test cobalamin levels and supplement if low - B12 deficiency worsens gut function
Taper prednisolone to the lowest effective maintenance dose once remission is achieved